These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28076787)

  • 21. Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells.
    Steinschulte C; Taner T; Thomson AW; Bein G; Hackstein H
    J Immunol; 2003 Jul; 171(2):542-6. PubMed ID: 12847216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.
    Zhang LH; Youn HD; Liu JO
    J Biol Chem; 2001 Nov; 276(47):43534-40. PubMed ID: 11557753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A.
    Steadman VA; Pettit SB; Poullennec KG; Lazarides L; Keats AJ; Dean DK; Stanway SJ; Austin CA; Sanvoisin JA; Watt GM; Fliri HG; Liclican AC; Jin D; Wong MH; Leavitt SA; Lee YJ; Tian Y; Frey CR; Appleby TC; Schmitz U; Jansa P; Mackman RL; Schultz BE
    J Med Chem; 2017 Feb; 60(3):1000-1017. PubMed ID: 28075591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
    Garat A; Cauffiez C; Hamdan-Khalil R; Glowacki F; Devos A; Leclerc J; Lionet A; Allorge D; Lo-Guidice JM; Broly F
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):841-7. PubMed ID: 19810816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeleton.
    Lake JI; Avetisyan M; Zimmermann AG; Heuckeroth RO
    Dev Biol; 2016 Jan; 409(1):152-165. PubMed ID: 26546974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression and prognostic role of IMPDH2 in ovarian cancer.
    Tian Y; Zhang J; Chen L; Zhang X
    Ann Diagn Pathol; 2020 Jun; 46():151511. PubMed ID: 32305001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inosine monophosphate dehydrogenase type1 sustains tumor growth in hepatocellular carcinoma.
    Jia X; Liu Y; Cheng Y; Wang Y; Kang H; Ma Z; Chen K
    J Clin Lab Anal; 2022 May; 36(5):e24416. PubMed ID: 35403278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophilin A is required for M-CSF-dependent macrophage proliferation.
    Sànchez-Tilló E; Wojciechowska M; Comalada M; Farrera C; Lloberas J; Celada A
    Eur J Immunol; 2006 Sep; 36(9):2515-24. PubMed ID: 16909430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymes Regulated via Cystathionine β-Synthase Domains.
    Anashkin VA; Baykov AA; Lahti R
    Biochemistry (Mosc); 2017 Oct; 82(10):1079-1087. PubMed ID: 29037129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cystathionine-β-synthase domains on the guanosine 5''-monophosphate reductase and inosine 5'-monophosphate dehydrogenase enzymes from Leishmania regulate enzymatic activity in response to guanylate and adenylate nucleotide levels.
    Smith S; Boitz J; Chidambaram ES; Chatterjee A; Ait-Tihyaty M; Ullman B; Jardim A
    Mol Microbiol; 2016 Jun; 100(5):824-40. PubMed ID: 26853689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMPDH2 forms spots at branching sites and distal ends of astrocyte stem processes.
    Toyoda S; Handa T; Yong H; Takahashi H; Shiwaku H
    Genes Cells; 2024 Feb; 29(2):150-158. PubMed ID: 38009721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism.
    Kofuji S; Sasaki AT
    J Biochem; 2020 Oct; 168(4):319-328. PubMed ID: 32702086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
    Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
    Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation.
    Johnson MC; Kollman JM
    Elife; 2020 Jan; 9():. PubMed ID: 31999252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation.
    O'Neill AG; Burrell AL; Zech M; Elpeleg O; Harel T; Edvardson S; Mor-Shaked H; Rippert AL; Nomakuchi T; Izumi K; Kollman JM
    J Biol Chem; 2023 Aug; 299(8):105012. PubMed ID: 37414152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAD-based inhibitors with anticancer potential.
    Felczak K; Vince R; Pankiewicz KW
    Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMP dehydrogenase-linked retinitis pigmentosa.
    Hedstrom L
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):839-49. PubMed ID: 18600550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
    Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
    Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.
    Kofuji S; Hirayama A; Eberhardt AO; Kawaguchi R; Sugiura Y; Sampetrean O; Ikeda Y; Warren M; Sakamoto N; Kitahara S; Yoshino H; Yamashita D; Sumita K; Wolfe K; Lange L; Ikeda S; Shimada H; Minami N; Malhotra A; Morioka S; Ban Y; Asano M; Flanary VL; Ramkissoon A; Chow LML; Kiyokawa J; Mashimo T; Lucey G; Mareninov S; Ozawa T; Onishi N; Okumura K; Terakawa J; Daikoku T; Wise-Draper T; Majd N; Kofuji K; Sasaki M; Mori M; Kanemura Y; Smith EP; Anastasiou D; Wakimoto H; Holland EC; Yong WH; Horbinski C; Nakano I; DeBerardinis RJ; Bachoo RM; Mischel PS; Yasui W; Suematsu M; Saya H; Soga T; Grummt I; Bierhoff H; Sasaki AT
    Nat Cell Biol; 2019 Aug; 21(8):1003-1014. PubMed ID: 31371825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of local GTP availability controls RAC1 activity and cell invasion.
    Bianchi-Smiraglia A; Wolff DW; Marston DJ; Deng Z; Han Z; Moparthy S; Wombacher RM; Mussell AL; Shen S; Chen J; Yun DH; O'Brien Cox A; Furdui CM; Hurley E; Feltri ML; Qu J; Hollis T; Kengne JBN; Fongang B; Sousa RJ; Kandel ME; Kandel ES; Hahn KM; Nikiforov MA
    Nat Commun; 2021 Oct; 12(1):6091. PubMed ID: 34667203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.